Livzon Pharmaceutical Group Inc 2023 Annual Report with Sustainability Disclosures
Company: Livzon Pharmaceutical Group Inc
Sector: Manufacturing
Country: China
Year: 2023
Type: Annual Report with Sustainability Disclosures
Pages: 498
The report covers 2023 operating income of RMB12,430.04 million, an MSCI ESG rating of AAA, and a stated goal of achieving carbon neutrality by 2055. It describes an ESG Committee under the Board, environmental and social responsibility activities, and energy-saving measures across key manufacturing subsidiaries. The report also records 8,933 employees at year-end and highlights talent development and employee diversity.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.